Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility

Michelle R. Jones, Gregorio Chazenbalk, Ning Xu, Angela K. Chua, Tamar Eigler, Emebet Mengesha, Yen Hao Chen, Jung Min Lee, Marita Pall, Xiaohui Li, Yii Der I. Chen, Kent D. Taylor, Ruchi Mathur, Ronald M. Krauss, Jerome I. Rotter, Richard S. Legro, Ricardo Azziz, Mark O. Goodarzi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Context: Polycystic ovary syndrome (PCOS) is a heterogeneous common genetic disorder characterized by hyperandrogenemia and insulin resistance. Alterations in gene expression profiles of the ovary and adipose tissue identified the candidate gene FBJ murine osteosarcoma viral oncogene homolog (FOS) for further investigation of expression changes in metabolic tissues and genetic studies. Objective: The objective of the study was to confirm the underexpression of the FOS gene in sc adipose and determine whether variants in this gene are risk factors for PCOS. Design: RT-PCR was performed in sc fat from women with and without PCOS. Genotyping of single-nucleotide polymorphisms in the FOS locus was performed to test for association with PCOS. Setting: The study was conducted at a tertiary care academic institution. Participants: Twenty-two PCOS and 13 control subjects were recruited for gene expression studies. We assembled a discovery genotyping cohort of 354 cases and 161 controls and a replication cohort of 476 cases and 315 controls, all of whom were Caucasian. Main Measurements: Gene expression by quantitative real-time RT-PCR, FOS genotype, and PCOS status were measured. Results: FOS expression was confirmed to be reduced in PCOS adipose tissue. Three single-nucleotide polymorphisms were significantly associated with PCOS in the discovery cohort (rs8006998, P = 0.0031; rs8013918, P = 0.0006; rs8013942, P = 0.0087). rs8006998 was also associated with PCOS in the replication cohort (P = 0.013). Conclusions: Differential gene expressionin sc fat and genetic association at the FOS locus in PCOS subjects implicates a role for this transcription factor in PCOS. FOS dysfunction may be a common factor between hyperandrogenism and insulin resistance.

Original languageEnglish (US)
Pages (from-to)E1750-E1757
JournalJournal of Clinical Endocrinology and Metabolism
Volume97
Issue number9
DOIs
StatePublished - Sep 1 2012

Fingerprint

Polycystic Ovary Syndrome
Adipose Tissue
Genes
Gene expression
Tissue
Polymorphism
Nucleotides
Fats
Insulin
Transcription Factors
Single Nucleotide Polymorphism
Insulin Resistance
Hyperandrogenism
Gene Expression
Inborn Genetic Diseases
Osteosarcoma
Tertiary Healthcare
Oncogenes
Transcriptome
Real-Time Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Jones, Michelle R. ; Chazenbalk, Gregorio ; Xu, Ning ; Chua, Angela K. ; Eigler, Tamar ; Mengesha, Emebet ; Chen, Yen Hao ; Lee, Jung Min ; Pall, Marita ; Li, Xiaohui ; Chen, Yii Der I. ; Taylor, Kent D. ; Mathur, Ruchi ; Krauss, Ronald M. ; Rotter, Jerome I. ; Legro, Richard S. ; Azziz, Ricardo ; Goodarzi, Mark O. / Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. In: Journal of Clinical Endocrinology and Metabolism. 2012 ; Vol. 97, No. 9. pp. E1750-E1757.
@article{e166a4470107473c8f0b1d54f9cb7c94,
title = "Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility",
abstract = "Context: Polycystic ovary syndrome (PCOS) is a heterogeneous common genetic disorder characterized by hyperandrogenemia and insulin resistance. Alterations in gene expression profiles of the ovary and adipose tissue identified the candidate gene FBJ murine osteosarcoma viral oncogene homolog (FOS) for further investigation of expression changes in metabolic tissues and genetic studies. Objective: The objective of the study was to confirm the underexpression of the FOS gene in sc adipose and determine whether variants in this gene are risk factors for PCOS. Design: RT-PCR was performed in sc fat from women with and without PCOS. Genotyping of single-nucleotide polymorphisms in the FOS locus was performed to test for association with PCOS. Setting: The study was conducted at a tertiary care academic institution. Participants: Twenty-two PCOS and 13 control subjects were recruited for gene expression studies. We assembled a discovery genotyping cohort of 354 cases and 161 controls and a replication cohort of 476 cases and 315 controls, all of whom were Caucasian. Main Measurements: Gene expression by quantitative real-time RT-PCR, FOS genotype, and PCOS status were measured. Results: FOS expression was confirmed to be reduced in PCOS adipose tissue. Three single-nucleotide polymorphisms were significantly associated with PCOS in the discovery cohort (rs8006998, P = 0.0031; rs8013918, P = 0.0006; rs8013942, P = 0.0087). rs8006998 was also associated with PCOS in the replication cohort (P = 0.013). Conclusions: Differential gene expressionin sc fat and genetic association at the FOS locus in PCOS subjects implicates a role for this transcription factor in PCOS. FOS dysfunction may be a common factor between hyperandrogenism and insulin resistance.",
author = "Jones, {Michelle R.} and Gregorio Chazenbalk and Ning Xu and Chua, {Angela K.} and Tamar Eigler and Emebet Mengesha and Chen, {Yen Hao} and Lee, {Jung Min} and Marita Pall and Xiaohui Li and Chen, {Yii Der I.} and Taylor, {Kent D.} and Ruchi Mathur and Krauss, {Ronald M.} and Rotter, {Jerome I.} and Legro, {Richard S.} and Ricardo Azziz and Goodarzi, {Mark O.}",
year = "2012",
month = "9",
day = "1",
doi = "10.1210/jc.2011-2153",
language = "English (US)",
volume = "97",
pages = "E1750--E1757",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

Jones, MR, Chazenbalk, G, Xu, N, Chua, AK, Eigler, T, Mengesha, E, Chen, YH, Lee, JM, Pall, M, Li, X, Chen, YDI, Taylor, KD, Mathur, R, Krauss, RM, Rotter, JI, Legro, RS, Azziz, R & Goodarzi, MO 2012, 'Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility', Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 9, pp. E1750-E1757. https://doi.org/10.1210/jc.2011-2153

Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. / Jones, Michelle R.; Chazenbalk, Gregorio; Xu, Ning; Chua, Angela K.; Eigler, Tamar; Mengesha, Emebet; Chen, Yen Hao; Lee, Jung Min; Pall, Marita; Li, Xiaohui; Chen, Yii Der I.; Taylor, Kent D.; Mathur, Ruchi; Krauss, Ronald M.; Rotter, Jerome I.; Legro, Richard S.; Azziz, Ricardo; Goodarzi, Mark O.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 97, No. 9, 01.09.2012, p. E1750-E1757.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility

AU - Jones, Michelle R.

AU - Chazenbalk, Gregorio

AU - Xu, Ning

AU - Chua, Angela K.

AU - Eigler, Tamar

AU - Mengesha, Emebet

AU - Chen, Yen Hao

AU - Lee, Jung Min

AU - Pall, Marita

AU - Li, Xiaohui

AU - Chen, Yii Der I.

AU - Taylor, Kent D.

AU - Mathur, Ruchi

AU - Krauss, Ronald M.

AU - Rotter, Jerome I.

AU - Legro, Richard S.

AU - Azziz, Ricardo

AU - Goodarzi, Mark O.

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Context: Polycystic ovary syndrome (PCOS) is a heterogeneous common genetic disorder characterized by hyperandrogenemia and insulin resistance. Alterations in gene expression profiles of the ovary and adipose tissue identified the candidate gene FBJ murine osteosarcoma viral oncogene homolog (FOS) for further investigation of expression changes in metabolic tissues and genetic studies. Objective: The objective of the study was to confirm the underexpression of the FOS gene in sc adipose and determine whether variants in this gene are risk factors for PCOS. Design: RT-PCR was performed in sc fat from women with and without PCOS. Genotyping of single-nucleotide polymorphisms in the FOS locus was performed to test for association with PCOS. Setting: The study was conducted at a tertiary care academic institution. Participants: Twenty-two PCOS and 13 control subjects were recruited for gene expression studies. We assembled a discovery genotyping cohort of 354 cases and 161 controls and a replication cohort of 476 cases and 315 controls, all of whom were Caucasian. Main Measurements: Gene expression by quantitative real-time RT-PCR, FOS genotype, and PCOS status were measured. Results: FOS expression was confirmed to be reduced in PCOS adipose tissue. Three single-nucleotide polymorphisms were significantly associated with PCOS in the discovery cohort (rs8006998, P = 0.0031; rs8013918, P = 0.0006; rs8013942, P = 0.0087). rs8006998 was also associated with PCOS in the replication cohort (P = 0.013). Conclusions: Differential gene expressionin sc fat and genetic association at the FOS locus in PCOS subjects implicates a role for this transcription factor in PCOS. FOS dysfunction may be a common factor between hyperandrogenism and insulin resistance.

AB - Context: Polycystic ovary syndrome (PCOS) is a heterogeneous common genetic disorder characterized by hyperandrogenemia and insulin resistance. Alterations in gene expression profiles of the ovary and adipose tissue identified the candidate gene FBJ murine osteosarcoma viral oncogene homolog (FOS) for further investigation of expression changes in metabolic tissues and genetic studies. Objective: The objective of the study was to confirm the underexpression of the FOS gene in sc adipose and determine whether variants in this gene are risk factors for PCOS. Design: RT-PCR was performed in sc fat from women with and without PCOS. Genotyping of single-nucleotide polymorphisms in the FOS locus was performed to test for association with PCOS. Setting: The study was conducted at a tertiary care academic institution. Participants: Twenty-two PCOS and 13 control subjects were recruited for gene expression studies. We assembled a discovery genotyping cohort of 354 cases and 161 controls and a replication cohort of 476 cases and 315 controls, all of whom were Caucasian. Main Measurements: Gene expression by quantitative real-time RT-PCR, FOS genotype, and PCOS status were measured. Results: FOS expression was confirmed to be reduced in PCOS adipose tissue. Three single-nucleotide polymorphisms were significantly associated with PCOS in the discovery cohort (rs8006998, P = 0.0031; rs8013918, P = 0.0006; rs8013942, P = 0.0087). rs8006998 was also associated with PCOS in the replication cohort (P = 0.013). Conclusions: Differential gene expressionin sc fat and genetic association at the FOS locus in PCOS subjects implicates a role for this transcription factor in PCOS. FOS dysfunction may be a common factor between hyperandrogenism and insulin resistance.

UR - http://www.scopus.com/inward/record.url?scp=84866153377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866153377&partnerID=8YFLogxK

U2 - 10.1210/jc.2011-2153

DO - 10.1210/jc.2011-2153

M3 - Article

C2 - 22723319

AN - SCOPUS:84866153377

VL - 97

SP - E1750-E1757

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -